# FDA Inspection 731242 - Central Jersey Blood Center, Inc. - June 15, 2011

Source: https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center-inc/37744504-f2b3-41a4-9ebd-feab48e2f335
Source feed: FDA_Inspections

> FDA Inspection 731242 for Central Jersey Blood Center, Inc. on June 15, 2011. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 731242
- Company Name: Central Jersey Blood Center, Inc.
- Inspection Date: 2011-06-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1003867 - 2017-02-27](https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center-inc/ba95b8e3-b076-41a9-b260-b52ef789131c)
- [FDA Inspection 904956 - 2014-11-17](https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center-inc/b2e70713-4f3d-41f3-ba23-b6fc325a7a59)
- [FDA Inspection 822475 - 2013-03-07](https://www.keypedia.com/records/fda_inspections/central-jersey-blood-center-inc/50e16b5c-a1b5-4d37-9360-9e9ef5db30d4)

Company: https://www.keypedia.com/companies/central-jersey-blood-center-inc/56962f1e-0357-4d4e-b918-f29199134127

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d